Evidence map›Paper›PMID 36813491›Full record

ArticleBMJ open2023

Patient perspectives on, and effects of, medication management in geriatric fallers (the EMMA study): protocol for a mixed-methods pre-post study.

Stephanie Buchegger, Bernhard Iglseder, Reinhard Alzner, Magdalena Kogler, Olaf Rose, Patrick Kutschar, Simon Krutter, Christina Dückelmann, Maria Flamm, Johanna Pachmayr

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Artificial intelligence to assist decision-making on pharmacotherapy: A feasibility study.Exploratory research in clinical and social pharmacy · 2024
    Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

Stephanie BucheggerInstitute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University Salzburg, Salzburg, Austria stephanie.buchegger@pmu.ac.at.ORCID 0000-0002-8788-9329
Bernhard IglsederDepartment of Geriatric Medicine, University Hospital Salzburg-Christian Doppler Hospital, Salzburg, Austria.
Reinhard AlznerDepartment of Geriatric Medicine, University Hospital Salzburg-Christian Doppler Hospital, Salzburg, Austria.
Magdalena KoglerDepartment of Clinical Pharmacy and Drug Information, Hospital Pharmacy, Landesapotheke Salzburg, Salzburg, Austria.
Olaf RoseDepartment of Research in Pharmacotherapy, Impac2t, Münster, Germany.
Patrick KutscharInstitute of Nursing Science and Practice, Paracelsus Medical University Salzburg, Salzburg, Austria.ORCID 0000-0002-2029-2552
Simon KrutterInstitute of Nursing Science and Practice, Paracelsus Medical University Salzburg, Salzburg, Austria.ORCID 0000-0001-5788-9574
Christina DückelmannInstitute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University Salzburg, Salzburg, Austria.
Maria FlammCenter of Public Health and Health Services Research, Paracelsus Medical University Salzburg, Salzburg, Austria.
Johanna PachmayrInstitute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University Salzburg, Salzburg, Austria.
Paracelsus Medical University · ATChristian Doppler Klinik · ATLandesa Rural Development Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPharmacotherapy is critical in geriatric fallers owing to the vulnerability of this population. Comprehensive medication management can be an important strategy to reduce the medication-related risk of falling in this patient group. Patient-specific approaches and patient-related barriers to this intervention have rarely been explored among geriatric fallers. This study will focus on establishing a comprehensive medication management process to provide better insights into patients' individual perceptions regarding their fall-related medication as well as identifying organisational and medical-psychosocial effects and challenges of this intervention. METHODS AND ANALYSIS: The study design is a complementary mixed-methods pre-post study which follows the approach of an embedded experimental model. Thirty fallers aged at least 65 years who were on five or more self-managed long-term drugs will be recruited from a geriatric fracture centre. The intervention consists of a five-step (recording, reviewing, discussion, communication, documentation) comprehensive medication management, which focuses on reducing the medication-related risk of falling. The intervention is framed using guided semi-structured pre-post interventional interviews, including a follow-up period of 12 weeks. These interviews will assess patients' perceptions of falls, medication-related risks and gauge the postdischarge acceptability and sustainability of the intervention. Outcomes of the intervention will be measured based on changes in the weighted and summated Medication Appropriateness Index score, number of fall-risk-increasing drugs and potentially inadequate medication according to the Fit fOR The Aged and PRISCUS lists. Qualitative and quantitative findings will be integrated to develop a comprehensive understanding of decision-making needs, the perspective of geriatric fallers and the effects of comprehensive medication management. ETHICS AND DISSEMINATION: The study protocol was approved by the local ethics committee of Salzburg County, Austria (ID: 1059/2021). Written informed consent will be obtained from all patients. Study findings will be disseminated through peer-reviewed journals and conferences. TRIAL REGISTRATION NUMBER: DRKS00026739.

Indexed as

AftercareMedication Therapy ManagementAgedHumansPatient DischargeResearch Designclinical pharmacologygeriatric medicinehealth & safetypreventive medicinequalitative researchsocial medicine

Identifiers

PMID36813491
PMCPMC9950918
OpenAlexW4321503945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.